Modulation of endotoxin-induced cardiopulmonary dysfunction by S-nitroso-albumin

Abstract

Nitric oxide (NO) is an endogenous vasodilator and modulator of inflammation. During endotoxemia, the beneficial effects of NO are overwhelmed by the inflammatory cascade, resulting in a functional depletion of NO. S-nitroso-albumin (S-NO-alb) exists as a novel and highly stable NO thiol complex that slowly releases NO into the vascular micro-environment. Using a porcine model, we examined the ability of intravenous S-NO-alb to modulate cardiopulmonary dysfunction characteristic of endotoxemia. Pigs were anesthetized, instrumented for standard cardiopulmonary function measurements, and randomly assigned to receive: (i) albumin + saline; (ii) albumin + LPS; or (iii) S-NO-alb + LPS. Cardiopulmonary parameters were evaluated every 30 min and ex vivo phorbol myristate acetate (PMA)-stimulated superoxide release was serially determined as a marker of in vivo neutrophil priming. Lung myeloperoxidase (MPO) activity was measured as a marker of neutrophil migration into the lung. LPS-induced cardiopulmonary dysfunction was characterized by a sustained elevation in mean pulmonary arterial pressure, pulmonary vascular resistance, and peak intratracheal pressure, as well as a reduction in cardiac index, stroke volume index and PaO₂ over 6 h. Pretreatment with S-NO-alb attenuated LPS-induced cardiopulmonary dysfunction without adversely affecting systemic hemodynamics. Moreover, S-NO-alb blunted the LPS-induced hypoxemic response and reduced neutrophil activation. S-NO-alb did not, however, attenuate LPS-induced increases in lung MPO. Our results suggest that S-NO-alb can selectively modulate endotoxin-induced pulmonary dysfunction, attenuate neutrophil priming and block the early mortality (40%) in this model.

References

Nava E. , Palmer Rmj , Moncada S.

Inhibition of nitric oxide synthesis in septic shock: how much is beneficial?

Lancet 1991; 338: 1555—1557.

Petros A. , Lamb G. , Leone A. , Moncada S. , Bennett D. , Vallance N. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1994; 28: 34—39.

Cobb JP , Natanson C. , Hoffman WD et al. Nω-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin. J Exp Med 1992; 176: 1175—1182.

Robertson FM , Offner PJ , Ciceri DP , Becker WK , Pruitt Jr BA Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 1994; 129: 149—156.

Armstead VE , Minchenko AG , Schuhl RA , Hayward R. , Nossuli TO , Lefer AM Regulation of P-selectin expression in human endothelial cells by nitric oxide . Am J Physiol 1997; 273: H740—H746.

Niu X. , Smith CW , Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res 1994; 74: 1133—1140.

Van Dervort AL , Yan L. , Madara PJ et al. Nitric oxide regulates endotoxin-induced TNF-α production by human neutrophils. J Immunol 1994; 152: 4102—4109.

Lefer AM , Siegried MR , Ma XL Protection of ischemia-reperfusion injury by sydnonimine NO donors via inhibition of neutrophil-endotheliuminteractions. J Cardiovasc Pharmacol 1993; 22: S27—S33.

Lefer DJ , Nakanishi K. , Vinten-Johansen J. Endothelial and myocardial cell protection by a cysteine-containing nitric oxide donor after myocardial ischemia and reperfusion. J Cardiovasc Pharmacol 1993; 22: S34—S43.

10.

László F. , Whittle Bjr , Moncada S. Attenuation by nitrosothiol NO donors of acute intestinal microvascular dysfunction in the rat. Br J Pharmacol 1995; 115: 498—502.

11.

Ichinose F. , Hurford WE , Zapol WM Evaluations of inhaled nitric oxide in experimental models of lung injury . In: Zapol WM , Bloch KD. (eds) Nitric Oxide and the Lung. New York, NY: Marcel Dekker, 1997 ;251-270.

12.

Gerlach H. , Falke KJ Low levels of inhaled nitric oxide in acute lung injury. In: Zapol WM , Bloch KD. (eds) Nitric Oxide and the Lung. New York, NY: Marcel Dekker, 1997;271-283.

13.

Bloomfield GL , Holloway S. , Ridings PC et al. Pretreatment with inhaled nitric oxide inhibits neutrophil migration and oxidative activity resulting in attenuated sepsis-induced acute lung injury. Crit Care Med 1997; 25:584—593.

14.

Tannenbaum SR Safety evaluation of inhaled nitric oxide. In: Zapol WM , Bloch KD. (eds) Nitric Oxide and the Lung. New York, NY: Marcel Dekker, 1997; 247—250.

15.

Gaston B. , Drazen JM , Loscalzo J. , Stamler JS The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med 1994; 149: 538—551.

16.

Feelisch M. The biochemical pathways of nitric oxide formation from nitrovasodilators: appropriate choice of exogenous NO donors and aspects of preparation and handling of aqueous solutions. J Cardiovasc Pharmacol 1991; 17: S25—S33.

17.

Bauer JA , Fung H. Differential hemodynamic effects and tolerance properties of nitroglycerin and an S-nitrosothiol in experimental heart failure. J Pharmacol Exp Ther 1991; 56: 249—254.

18.

Stamler JS , Jaraki O. , Osborne J. et al. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 1992; 89: 7674—7677.

19.

Keaney JF , Simon DI , Stamler JS et al. NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Invest 1993; 91: 1582—1589.

20.

Ewing JF , Young DV , Janero DR , Garvey DS , Grinnell TA Nitrosylated bovine serum albumin derivatives as pharmacologically active nitric oxide congeners. J Pharmacol Exp Ther 1997; 283: 947—954.

21.

Gluckman TL , Grossman JE , Folts JD , Kruse-Elliott KT Regulation of leukocyte function by nitric oxide donors: the effect of S-nitroso-thiols complexes. J Toxicol Environ Health 2000; 61: 9—26.

22.

Saville B. A scheme for colorimetric determination of microgram amounts of thiols. Analyst 1958; 83: 670—672.

23.

Kruse-Elliott KT Pulmonary and neutrophil responses to priming effects of platelet-activating factor in pigs. Am J Vet Res 1997; 58: 1386—1391.

24.

Olson NC , Brown TT , Anderson DL Dexamethasone and indomethacin modify endotoxin-induced respiratory failure in pigs. J Appl Physiol 1985;58: 274—284.

25.

Olsen NC Salzer WL, McCall CE. Biochemical, physiological and clinical aspects of endotoxemia . Mol Aspects Med 1988; 10: 511—629.

26.

Kruse-Elliott KT , Albert DH , Summers JB , Carter GW , Zimmerman JJ , Grossman JE Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonist. Shock 1996; 5: 265—273.

27.

Marks DS , Vita JA , Folts JD , Keaney JF , Welch GN , Loscalzo J. Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J Clin Invest 1995; 96: 2630—2638.

28.

Maleej N. , Albrecht R. , Loscalzo J. , Folts JD The potent platelet inhibitory effects of S-nitrosated albumin coating of artificial surfaces. J Am Coll Cardiol 1999 ; 33: 1408—1414.

29.

Dahm, PL , Jonson B. , De Robertis E. et al. The effects of nitric oxide inhalation on respiratory mechanics and gas exchange during endotoxaemia in the pig. Acta Anaethesiol Scand 1998; 42: 536—544.

30.

Weitzberg E. , Rudehill A. , Lundberg JM Nitric oxide inhalation attenuates pulmonary hypertension and improves gas exchange in endotoxin shock. Eur J Pharmacol 1993; 233: 85—94.

31.

Kadowitz PJ , Nandiwada P. , Gruetter CA , Ignarro LJ , Hyman AL Pulmonary vasodilator responses to nitroprusside and nitroglycerin in the dog. J Clin Invest 1981; 67: 893—902.

32.

Brilli RJ , Krafte-Jacobs B. , Smith DJ , Passerini D. , Moore L. , Ballard ET Aerosolization of novel nitric oxide donors selectively reduce pulmonary hypertension . Crit Care Med 1998; 26: 1390—1396.

33.

Jacobs BR , Brilli RJ , Ballard ET , Passerini DJ , Smith DJ Aerosolized soluble nitric oxide donor improves oxygenation and pulmonary hypertension in acute lung injury. Am J Respir Crit Care Med 1998; 158: 1536—1542.

34.

Jansen A. , Drazen J. , Osborne JA , Brown R. , Loscalzo J. , Stamler JS The relaxant properties of guinea pig airways of S-nitrosothiols. J Pharmacol Exper Ther 1992; 261:154—160.

35.

Clancy RM , Leszczynska-Piziak J. , Abramson SB Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 1992; 90: 1116—1121.

36.

McDonough KH , Smith T. , Patel K. , Quinn M. Myocardial dysfunction in the septic rat heart: role of nitric oxide. Shock 1998; 10: 371—376.